The journey
From the Mauritius final to the world stage
- Mauritius champion
TIBOK wins the first Startup World Cup regional final in Mauritius, against ten finalists.
- Among some 200
The Mauritian champion joins the roughly 200 regional champions selected worldwide for San Francisco.
- First pitch
In front of the semifinal jury. On the evening of the 5th, the Top 10 is announced: TIBOK is not in it.
- Back on stage
A second pitch, in front of hundreds of investors, on Grand Finale day.
On film
The week, seen from the inside
What TIBOK does
The operating system for primary care
TIBOK connects the patient, the doctor and the entire care chain, by teleconsultation or in the clinic: e-prescriptions, pharmacies, medication delivery, insurers. The doctor decides; AI saves them time.
Evidence-based AI
The clinical engine draws on guidelines from 15 health authorities and medical societies (WHO, NICE, HAS, CDC, ESC, ADA, KDIGO…), updated through daily monitoring and validated by doctors.
An agent for the doctor
The EVA agent prepares each consultation, online or in person, and saves the doctor time with every patient.
Vendor-independent
TIBOK uses several leading AI models (Claude, GPT, DeepSeek) and picks the best fit for each task, with automatic failover.
Ready to deploy
A clinic, an insurer or a distributor can deploy TIBOK to run full primary care with its own doctors.
What we bring back
Questioning ourselves, with the numbers to show it
The study of the 151 finalists does not spare us either. The Top 10 stands out for proof that TIBOK has yet to gather.
- Turn contracts into usage. Contracts with insurers must become thousands of consultations a month.
- Create an investor signal. 70% of the Top 10 had raised at least $5M; TIBOK is self-funded.
- Go beyond the home market. Madagascar must become a second active market, with patients and doctors.
- Publish results. Clinical validation, doctor time saved, costs avoided for the insurer.
| Criterion | Score | Reading |
|---|---|---|
| Disruption | 6 | Ambitious integration in a known category |
| Business model strength | 5 | Signed with insurers, not yet proven by usage |
| Market | 9 | Global market of $137bn to $203bn, highly scalable |
| Risk | 7 | Small team, health and AI regulation, self-funding |
Score set by the author using the same grid as the other 150 finalists, based on data partly self-reported by TIBOK. Read with this caveat in mind.
Notebook
San Francisco, between two pitches
